Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus-Reference-Cited by-同舟云学术

Systematic Review: Monoclonal Antibody-Induced Subacute Cutaneous Lupus Erythematosus

Published:2020-09-22 Issue:4 Volume:20 Page:319-330
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Bolton Chrissy^ORCID,Chen Yifan,Hawthorne Rachel,Schepel Ianthe R. M.,Harriss Elinor,Hofmann Silke C.,Ellis Spencer,Clarke Alexander,Wace Helena,Martin Blanca,Smith Joel

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40268-020-00320-5.pdf

Reference71 articles.

1. Giovanni MA, Murray MF. Genome-first findings require precision phenotyping. Genet Med. 2018;20:1510–1.

2. Loscalzo J, Kohane I, Barabasi A-L. Human disease classification in the postgenomic era: a complex systems approach to human pathobiology. Mol Syst Biol. 2007;3:124.

3. Kohane IS. Deeper, longer phenotyping to accelerate the discovery of the genetic architectures of diseases. Genome Biol. 2014;15:115.

4. Robinson PN, Mungall CJ, Haendel M. Capturing phenotypes for precision medicine. Cold Spring Harb Mol Case Stud. 2015;1:a000372.

5. Robinson PN, Köhler S, Bauer S, et al. The human phenotype ontology: a tool for annotating and analyzing human hereditary disease. Am J Hum Genet. 2008;83:610–5.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lupus Erythematosus and Antiphospholipid Syndrome;Rook's Textbook of Dermatology;2024-03-19

2. Immune checkpoint inhibitor-induced subacute cutaneous lupus erythematosus: a case report and review of the literature;Frontiers in Medicine;2024-02-01

3. Manifestation of subacute cutaneous lupus erythematosus during treatment with anti-PD-1 antibody cemiplimab – a case report;Frontiers in Immunology;2023-12-08

4. The Possible Clinical Significance of a Decreased Serum Level of Soluble PD-L1 in Discoid Lupus Erythematosus, but Not in Subacute Cutaneous Lupus Erythematosus—A Pilot Study;Journal of Clinical Medicine;2023-08-30

5. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07